BRITTANY ZOTO: Open Payments
NPI 1649052697 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $138 |
| Indivior Inc. | 4 | $95 |
| Braeburn Inc. | 3 | $85 |
| Orexo US, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
Products named: INGREZZA, SUBLOCADE, BRIXADI, Zubsolv, UZEDY, FANAPT, VRAYLAR.
Industry payments across WA — which companies pay providers there.
